- Report
- August 2026
- 170 Pages
Global
From €3641EUR$3,950USD£3,067GBP
- Report
- August 2026
- 180 Pages
Global
From €3641EUR$3,950USD£3,067GBP
- Report
- August 2026
- 176 Pages
Global
From €3641EUR$3,950USD£3,067GBP
- Report
- May 2026
- 154 Pages
Global
From €3641EUR$3,950USD£3,067GBP
- Report
- April 2026
- 160 Pages
Global
From €3060EUR$3,320USD£2,578GBP
€3825EUR$4,150USD£3,222GBP
- Report
- July 2026
- 160 Pages
Global
From €3060EUR$3,320USD£2,578GBP
€3825EUR$4,150USD£3,222GBP
- Report
- April 2026
- 160 Pages
Global
From €3060EUR$3,320USD£2,578GBP
€3825EUR$4,150USD£3,222GBP
- Report
- November 2025
- 160 Pages
Global
From €2913EUR$3,160USD£2,454GBP
€3641EUR$3,950USD£3,067GBP
- Report
- November 2025
- 160 Pages
Global
From €2913EUR$3,160USD£2,454GBP
€3641EUR$3,950USD£3,067GBP
- Report
- February 2026
- 82 Pages
Global
From €3500EUR$4,068USD£3,052GBP
- Report
- December 2025
- 150 Pages
Global
From €4470EUR$4,850USD£3,766GBP
- Report
- June 2026
- 52 Pages
Global
From €6913EUR$7,500USD£5,824GBP
- Report
- May 2026
- 130 Pages
Global
From €4470EUR$4,850USD£3,766GBP
- Report
- October 2025
- 90 Pages
Global
From €4148EUR$4,500USD£3,494GBP
- Report
- November 2025
- 130 Pages
Middle East
From €5484EUR$5,950USD£4,620GBP
- Report
- November 2025
- 150 Pages
Middle East
From €5484EUR$5,950USD£4,620GBP
- Report
- December 2025
- 150 Pages
United States
From €4470EUR$4,850USD£3,766GBP
- Report
- October 2025
- 83 Pages
Middle East
From €4148EUR$4,500USD£3,494GBP
- Report
- September 2023
- 270 Pages
Global
From €2258EUR$2,450USD£1,902GBP
- Report
- April 2022
- 302 Pages
Global
From €3456EUR$3,750USD£2,912GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more